PIK3R1 and glioblastoma: On the other hand, PIK3R1 mutations were found in 13.3% of the LEB-GBM patients (95% CI: 4.7–21.9) compared to 11.0% of the patients in the TCGA cohort (95% CI; 7.9–14.1).